Beta Bionics Files 2024 10-K Amendment
Ticker: BBNX · Form: 10-K/A · Filed: Mar 28, 2025 · CIK: 1674632
| Field | Detail |
|---|---|
| Company | Beta Bionics, Inc. (BBNX) |
| Form Type | 10-K/A |
| Filed Date | Mar 28, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, financials, customer-concentration, ipo
TL;DR
Beta Bionics amended its 2024 10-K, revealing IPO details and customer concentration risks.
AI Summary
Beta Bionics, Inc. filed an amendment to its 2024 10-K on March 28, 2025, detailing its fiscal year ending December 31, 2024. The filing includes information on its common stock, preferred stock, and revenue recognition, with specific disclosures related to customer concentration risk from Distributor A. The company also reported on subsequent events, including its IPO which occurred after January 31, 2025.
Why It Matters
This amendment provides updated financial and operational details for Beta Bionics, Inc. for the fiscal year 2024, crucial for investors assessing the company's performance and future prospects.
Risk Assessment
Risk Level: medium — The filing mentions customer concentration risk with Distributor A, indicating potential reliance on a single major customer.
Key Numbers
- 1231 — Fiscal Year End (The company's financial reporting period concludes on December 31st.)
- 2024 — Reporting Period (The 10-K/A amendment pertains to the fiscal year 2024.)
Key Players & Entities
- Beta Bionics, Inc. (company) — Filer
- Distributor A (company) — Customer
- Boston University (company) — Related Party
- 2024-12-31 (date) — Fiscal Year End
- 2025-03-28 (date) — Filing Date
- 2025-01-31 (date) — Subsequent Event Date
FAQ
What is the nature of the customer concentration risk mentioned with Distributor A?
The filing indicates customer concentration risk related to Distributor A, suggesting a significant portion of revenue may be derived from this single distributor.
When did Beta Bionics, Inc. file this amendment to its 10-K?
Beta Bionics, Inc. filed this 10-K/A on March 28, 2025.
What fiscal year does this 10-K/A filing cover?
This filing covers the fiscal year ending December 31, 2024.
Were there any significant events after the fiscal year end that are disclosed?
Yes, the filing discloses subsequent events, including the company's IPO which occurred after January 31, 2025.
Does the filing mention any related party transactions or relationships?
Yes, the filing mentions a relationship with Boston University as a related party.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on March 28, 2025 regarding Beta Bionics, Inc. (BBNX).